Are you planning to attend Antibody Engineering & Therapeutics Europe 2025 in Basel, Switzerland between June 10-12?

If so, make sure to connect with Abzena at the event. Our scientific experts will be on hand to discuss all your complex antibody engineering and development needs. Learn how our antibody design and protein engineering teams can de-risk your biologic development program.

At Abzena, we work to give you the best chance of success by combining over 20 years of protein engineering with state-of-the-art analytics services.

Event Details:

Dates: June 10-12
Location: Basel, Switzerland
Event website: Antibody Engineering & Therapeutics Europe 2025

Our experts will be on hand to provide you with an update on our expanded global capabilities and enhanced platform technology like AbZelectPRO™, our enhanced cell line development solution. AbZelectPRO™ can take you from DNA to RCB in 10 weeks with 8g/L in high-performing titers. If you are ready to achieve more from your cell line and reach IND faster, discover AbZelectPRO™.

Complete the form below to schedule a meeting and learn how Abzena’s integrated solutions can help accelerate your biologic drug development journey.

About Abzena

Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. We have research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.